Funder
National Institutes of Health
Reference31 articles.
1. Development of cross-reactive live attenuated influenza vaccine candidates against both lineages of influenza b virus;Wong;Vaccines. (Basel),2024
2. Genetic characterization of Influenza A(H1N1)pdm09 virus in 2023 in Huzhou;Xu;China. J. Clin.Virol. Plus,2024
3. Natural history of Influenza B virus-current knowledge on treatment, resistance and therapeutic options;Din;Curr. Issues. Mol. Biol.,2023
4. Quantifying the impact of COVID-19 Nonpharmaceutical interventions on Influenza transmission in the United States;Qi;J. Infect. Dis.,2021
5. Epidemiology of influenza over a ten-year period in Belgium: overview of the historical and current evidence;Prezzi;Virol. J.,2023